INO
Inovio Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
INO fundamentals
During Q4 2025, Inovio Pharmaceuticals (INO) reported revenue of --, a YoY change of 0.00%. Net income was 3.76M, a YoY change of 119.42%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q2,2015 | Q3,2015 | Q4,2015 | Q1,2016 | Q2,2016 | Q3,2016 | Q4,2016 | Q1,2017 | Q2,2017 | Q3,2017 | Q4,2017 | Q1,2018 | Q2,2018 | Q3,2018 | Q4,2018 | Q1,2019 | Q2,2019 | Q3,2019 | Q4,2019 | Q1,2020 | Q2,2020 | Q3,2020 | Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | Q4,2025 | TTM |
|---|
Start Date | Apr 1, 2015 | Jul 1, 2015 | Oct 1, 2015 | Jan 1, 2016 | Apr 1, 2016 | Jul 1, 2016 | Oct 1, 2016 | Jan 1, 2017 | Apr 1, 2017 | Jul 1, 2017 | Oct 1, 2017 | Jan 1, 2018 | Apr 1, 2018 | Jul 1, 2018 | Oct 1, 2018 | Jan 1, 2019 | Apr 1, 2019 | Jul 1, 2019 | Oct 1, 2019 | Jan 1, 2020 | Apr 1, 2020 | Jul 1, 2020 | Oct 1, 2020 | Jan 1, 2021 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | Oct 1, 2025 | -- |
End Date | Jun 30, 2015 | Sep 30, 2015 | Dec 31, 2015 | Mar 31, 2016 | Jun 30, 2016 | Sep 30, 2016 | Dec 31, 2016 | Mar 31, 2017 | Jun 30, 2017 | Sep 30, 2017 | Dec 31, 2017 | Mar 31, 2018 | Jun 30, 2018 | Sep 30, 2018 | Dec 31, 2018 | Mar 31, 2019 | Jun 30, 2019 | Sep 30, 2019 | Dec 31, 2019 | Mar 31, 2020 | Jun 30, 2020 | Sep 30, 2020 | Dec 31, 2020 | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | 5.29M -- | 24.18M -- | 5.94M -- | 8.11M -- | 6.20M +17.35% | 12.54M -48.14% | 8.51M +43.44% | 10.38M +27.94% | 20.41M +229.03% | 2.64M -78.91% | 8.79M +3.21% | 1.53M -85.26% | 24.45M +19.78% | 2.00M -24.34% | 2.50M -71.52% | 2.83M +85.00% | 135.67K -99.45% | 866.86K -56.68% | 279.49K -88.83% | 1.33M -53.10% | 267.19K +96.93% | 236.18K -72.75% | 5.58M +1896.72% | 371.12K -72.04% | 272.82K +2.11% | 291.70K +23.51% | 839.12K -84.96% | 199.07K -46.36% | 784.39K +187.51% | 9.15M +3038.22% | 124.67K -85.14% | 114.94K -42.26% | 225.97K -71.19% | 388.45K -95.76% | 102.65K -17.66% | -- -- | 100.76K -55.41% | 0 -100.00% | 116.99K +13.97% | 65.34K -- | -- -- | 0 -- | -- -- | -- -- |
Sales and Services Revenue | 5.29M -- | 24.18M -- | 5.94M -- | 8.11M -- | 6.20M +17.35% | 12.54M -48.14% | 8.51M +43.44% | 10.38M +27.94% | 20.41M +229.03% | 2.64M -78.91% | 8.79M +3.21% | 1.53M -85.26% | 24.45M +19.78% | 2.00M -24.34% | 2.50M -71.52% | 2.83M +85.00% | 135.67K -99.45% | 866.86K -56.68% | 40.15K -98.40% | 1.33M -53.10% | 267.19K +96.93% | 236.18K -72.75% | 5.58M +13798.64% | 371.12K -72.04% | 272.82K +2.11% | 291.70K +23.51% | 839.12K -84.96% | 199.07K -46.36% | 784.39K +187.51% | 9.15M +3038.22% | 124.67K -85.14% | 114.94K -42.26% | 225.97K -71.19% | 388.45K -95.76% | 102.65K -17.66% | 0 -100.00% | 100.76K -55.41% | 0 -100.00% | 116.99K +13.97% | 65.34K -- | 0 -100.00% | 0 -- | 0 -100.00% | 65.34K -- |
Other Revenue | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 239.34K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Cost of Revenue | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Gross Profit | 5.29M -- | 24.18M -- | 5.94M -- | 8.11M -- | 6.20M +17.35% | 12.54M -48.14% | 8.51M +43.44% | 10.38M +27.94% | 20.41M +229.03% | 2.64M -78.91% | 8.79M +3.21% | 1.53M -85.26% | 24.45M +19.78% | 2.00M -24.34% | 2.50M -71.52% | 2.83M +85.00% | 135.67K -99.45% | 866.86K -56.68% | -3.83M -253.14% | 1.33M -53.10% | 267.19K +96.93% | 236.18K -72.75% | -1.83M +52.23% | 371.12K -72.04% | 272.82K +2.11% | 291.70K +23.51% | -935.64K +48.89% | 199.07K -46.36% | 784.39K +187.51% | 9.15M +3038.22% | -10.14M -983.49% | 114.94K -42.26% | 225.97K -71.19% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Expenses | 20.41M -- | 20.45M -- | 20.46M -- | 23.56M -- | 24.43M +19.72% | 32.74M +60.06% | 30.88M +50.90% | 32.31M +37.14% | 30.05M +22.99% | 31.83M -2.77% | 31.68M +2.58% | 34.28M +6.08% | 29.65M -1.32% | 28.64M -10.01% | 32.00M +1.03% | 31.36M -8.49% | 28.34M -4.44% | 24.82M -13.35% | 30.70M -4.07% | 26.56M -15.32% | 33.45M +18.04% | 36.57M +47.33% | 34.92M +13.74% | 52.93M +99.27% | 83.47M +149.57% | 60.24M +64.76% | 106.35M +204.55% | 71.93M +35.91% | 104.92M +25.69% | 44.91M -25.45% | 56.07M -47.28% | 44.07M -38.74% | 37.27M -64.48% | 35.94M -19.97% | 27.50M -50.96% | 31.48M -28.55% | 33.30M -10.65% | 27.35M -23.91% | 20.49M -25.49% | 25.12M -20.23% | 23.08M -30.67% | 21.21M -22.44% | 17.48M -14.69% | 86.89M -- |
Selling, General and Administrative Expenses | 4.72M -- | 4.38M -- | 4.86M -- | 5.37M -- | 5.80M +22.92% | 5.76M +31.48% | 6.97M +43.32% | 7.77M +44.60% | 6.17M +6.37% | 6.32M +9.80% | 8.03M +15.34% | 9.70M +24.85% | 7.19M +16.54% | 6.79M +7.47% | 5.64M -29.85% | 6.98M -28.08% | 5.85M -18.63% | 5.68M -16.35% | 8.70M +54.30% | 7.45M +6.79% | 11.07M +89.25% | 10.11M +77.96% | 8.62M -0.91% | 13.88M +86.37% | 12.67M +14.40% | 13.16M +30.12% | 14.05M +63.03% | 15.95M +14.93% | 48.46M +282.56% | 11.82M -10.13% | 13.95M -0.70% | 13.89M -12.93% | 13.52M -72.09% | 9.93M -16.06% | 10.24M -26.58% | 10.57M -23.90% | 10.21M -24.52% | 8.61M -13.21% | 7.60M -25.79% | 9.02M -14.63% | 8.56M -16.10% | 7.88M -8.55% | 7.22M -5.07% | 32.68M -- |
General and Administrative Expenses | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 27.20M -- | -- -- | -- -- | -- -- | 37.25M +36.92% | -- -- | -- -- | -- -- | 53.75M +44.31% | -- -- | -- -- | -- -- | 90.19M +67.78% | -- -- | -- -- | 9.93M -- | 10.24M -88.64% | 10.57M -- | 10.21M -- | 8.61M -13.21% | 7.60M -25.79% | 9.02M -14.63% | 8.56M -16.10% | 7.88M -8.55% | 7.22M -5.07% | 32.68M -- |
Research and Development Expenses | 16.69M -- | 16.08M -- | 15.60M -- | 18.19M -- | 19.63M +17.63% | 26.98M +67.84% | 23.91M +53.26% | 24.54M +34.93% | 23.88M +21.64% | 25.51M -5.45% | 24.64M +3.05% | 24.58M +0.14% | 22.46M -5.93% | 21.85M -14.34% | 26.37M +7.00% | 24.39M -0.76% | 22.49M +0.11% | 19.14M -12.42% | 22.00M -16.54% | 19.11M -21.64% | 22.38M -0.49% | 26.46M +38.24% | 26.30M +19.54% | 39.04M +104.30% | 70.81M +216.44% | 47.09M +77.99% | 92.30M +250.91% | 55.98M +43.37% | 56.46M -20.26% | 33.09M -29.73% | 42.12M -54.37% | 30.18M -46.09% | 23.74M -57.95% | 15.50M -53.14% | 17.25M -59.04% | 20.91M -30.70% | 23.09M -2.75% | 18.73M +20.84% | 12.89M -25.31% | 16.09M -23.06% | 14.52M -37.11% | 13.33M -28.83% | 10.26M -20.37% | 54.21M -- |
Loss on Impairment of Other Assets | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | 10.51M -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Other Operating Expenses | -1.00M -- | -- -- | 0 -- | -- -- | -1.00M -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -1.00M -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Income | -15.12M -- | 3.73M -- | -14.53M -- | -15.45M -- | -18.23M -20.55% | -20.20M -641.37% | -22.36M -53.95% | -21.93M -41.96% | -9.64M +47.13% | -29.19M -44.51% | -22.89M -2.35% | -32.75M -49.29% | -5.20M +46.00% | -26.64M +8.71% | -29.50M -28.89% | -28.54M +12.86% | -28.20M -441.99% | -23.95M +10.10% | -30.42M -3.13% | -25.23M +11.57% | -33.18M -17.66% | -36.33M -51.68% | -29.34M +3.56% | -52.55M -108.28% | -83.20M -150.75% | -59.95M -65.03% | -105.51M -259.61% | -71.73M -36.49% | -104.14M -25.16% | -35.76M +40.36% | -55.95M +46.97% | -43.95M +38.73% | -37.04M +64.43% | -35.55M +0.57% | -27.39M +51.04% | -31.48M +28.37% | -33.20M +10.38% | -27.35M +23.08% | -20.37M +25.64% | -25.05M +20.44% | -23.08M +30.46% | -21.21M +22.44% | -17.48M +14.20% | -86.82M -- |
Non-Operating Income (Loss) | 8.96M -- | 74.81K -- | -3.73M -- | 7.41M -- | -478.17K -105.34% | -563.86K -853.77% | -3.87M -3.64% | -1.15M -115.55% | 156.62K +132.75% | -4.95M -777.73% | 1.38M +135.70% | 2.57M +322.67% | -1.44M -1016.86% | 1.63M +132.87% | -3.46M -350.65% | -816.65K -131.84% | -1.49M -3.43% | 415.33K -74.47% | -7.81M -125.64% | -7.90M -867.74% | -95.99M -6363.41% | 55.50M +13262.89% | 9.59M +222.67% | -1.85M +76.62% | 1.06M +101.11% | -215.89K -100.39% | -1.00M -110.48% | -7.34M -297.30% | -4.36M -510.55% | -2.03M -838.85% | 3.65M +463.06% | 3.30M +144.99% | 1.51M +134.55% | 1.62M +180.08% | 2.39M -34.49% | 1.02M -69.27% | 959.82K -36.29% | 2.18M +34.43% | 987.88K -58.67% | 5.36M +427.62% | -434.89K -145.31% | -24.29M -1213.03% | 21.24M +2050.20% | 1.88M -- |
Income (Loss) from Affiliates | 8.86M -- | -659.05K -- | -3.25M -- | 7.48M -- | -705.53K -107.96% | -958.14K -45.38% | -4.71M -44.85% | -1.61M -121.51% | 169.10K +123.97% | -5.84M -509.07% | 292.80K +106.22% | 2.38M +247.96% | -2.09M -1337.53% | 1.02M +117.43% | -3.29M -1224.92% | -750.10K -131.51% | -173.21K +91.72% | -485.84K -147.76% | 1.41M +142.78% | 13.18M +1857.31% | -4.78M -2662.47% | 25.19M +5285.28% | -33.59M -2483.62% | -434.39K -103.30% | 278.82K +105.83% | -22.00K -100.09% | 1.01M +103.00% | -2.17M -398.45% | -934.01K -434.99% | -305.06K -1286.70% | 3.94M +291.06% | 616.64K +128.48% | 156.75K +116.78% | -- -- | -- -- | -- -- | -- -- | 324.25K -- | 136.06K -- | -- -- | -- -- | -589.62K -281.84% | -881.89K -748.15% | -- -- |
Gain (Loss) on Other Investment | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -3.09M -- | -- -- | -- -- | -- -- | 38.25M +1337.71% | -- -- | -- -- | -- -- | -3.78M -109.87% | -- -- | -- -- | -- -- | -9.75M -158.07% | -- -- | -- -- | 214.37K -- | 5.64M +157.83% | -126.02K -- | -355.11K -- | -- -- | 910.74K -83.84% | 695.13K +651.61% | 1.54M +532.44% | -- -- | 1.60M +76.19% | -- -- |
Gain (Loss) on Change in Fair Value | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -1.76M -- | -- -- | -- -- | -- -- | -75.67M -4190.58% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -219.34K -- | -3.92M -- | 500.88K -- | 0 -- | 0 +100.00% | 2.81M +171.61% | 3.85M +669.27% | -1.88M -- | -22.52M -- | 21.17M +653.90% | 633.47K -- |
Other Non-Operating Income (Loss) | 96.56K -- | 733.86K -- | -484.83K -- | -73.18K -- | 227.36K +135.46% | 394.29K -46.27% | 836.35K +272.50% | 456.82K +724.25% | -12.48K -105.49% | 886.64K +124.87% | -721.71K -186.29% | 184.68K -59.57% | 138.13K +1206.88% | 44.61K -94.97% | -785.06K -8.78% | -35.84K -119.41% | 127.51K -7.68% | 2.69M +5935.03% | -2.29M -191.43% | -18.70M -52071.01% | -89.43M -70232.53% | 31.40M +1066.09% | 80.73M +3628.60% | -1.67M +91.07% | 321.77K +100.36% | -483.79K -101.54% | 1.34M -98.33% | -5.53M -231.36% | -3.97M -1333.83% | -2.77M -473.41% | 7.88M +485.91% | 792.54K +114.33% | -504.93K +87.28% | 2.85K +100.10% | -860.91K -110.93% | -682.22K -186.08% | 7.57K +101.50% | 750.99K +26213.67% | -3.72M -332.12% | -482 +99.93% | -703.18K -9387.85% | -1.73M -330.76% | -1.10M +70.30% | -3.54M -- |
Net Interest Expense | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -1.81M -- | -- -- | -518.52K -- | -565.04K -- | -615.76K +65.99% | 30.71K -- | 1.44M +377.61% | 1.79M +417.01% | 2.08M +437.98% | 2.39M +7672.56% | 1.78M +23.61% | 1.09M -39.30% | 136.84K -93.42% | -256.20K -110.73% | -461.38K -125.93% | -289.90K -126.66% | -419.15K -406.31% | -356.33K -39.08% | -544.18K -17.94% | -1.05M -262.98% | -1.58M -275.83% | -1.89M -431.45% | -1.85M -240.83% | -1.63M -54.45% | -1.54M +2.44% | -1.32M +30.16% | -1.31M +29.51% | -1.11M +31.90% | -852.59K +44.52% | -808.08K +38.90% | -610.64K +53.29% | -552.11K +50.11% | -449.34K +47.30% | -2.42M -- |
Interest Expense | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 25.93K -- | -- -- | 0 -- | 0 -- | 0 -100.00% | 656.25K -- | 2.19M -- | 2.43M -- | 2.67M -- | 2.80M +327.24% | 2.85M +29.70% | 1.98M -18.31% | 1.07M -59.98% | 513.03K -81.70% | 466.73K -83.60% | 476.37K -75.99% | 480.31K -55.03% | 313.49K -38.90% | 313.49K -32.83% | 313.49K -34.19% | 313.49K -34.73% | 313.49K -- | 313.49K -- | 313.49K -- | 282.32K -9.94% | 177.83K -43.27% | 0 -100.00% | 0 -100.00% | 0 -100.00% | 0 -100.00% | 0 -- | 0 -- | 0 -- | -- -- |
Interest Income | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 1.84M -- | -- -- | 518.52K -- | 565.04K -- | 615.76K -66.47% | 625.53K -- | 755.33K +45.67% | 637.44K +12.81% | 587.68K -4.56% | 416.57K -33.41% | 1.07M +41.32% | 896.71K +40.67% | 931.17K +58.45% | 769.24K +84.66% | 928.11K -13.05% | 766.27K -14.55% | 899.46K -3.40% | 669.81K -12.92% | 857.67K -7.59% | 1.37M +78.23% | 1.89M +109.99% | 2.21M +229.52% | 2.17M +152.81% | 1.94M +41.95% | 1.82M -3.69% | 1.50M -32.03% | 1.31M -39.70% | 1.11M -42.91% | 852.59K -53.13% | 808.08K -46.14% | 610.64K -53.29% | 552.11K -50.11% | 449.34K -47.30% | 2.42M -- |
Pretax Income From Continuing Operations | -6.16M -- | 3.81M -- | -18.26M -- | -8.04M -- | -18.70M -203.53% | -20.76M -645.55% | -26.23M -43.66% | -23.09M -187.04% | -9.48M +49.32% | -34.13M -64.43% | -21.51M +18.02% | -30.18M -30.73% | -6.64M +29.96% | -25.02M +26.71% | -32.96M -53.27% | -29.35M +2.75% | -29.69M -347.13% | -23.54M +5.91% | -38.24M -16.00% | -33.14M -12.89% | -129.17M -335.13% | 19.17M +181.45% | -24.34M +36.35% | -54.40M -64.18% | -82.14M +36.41% | -60.17M -413.85% | -106.95M -339.42% | -79.07M -45.35% | -108.50M -32.09% | -37.78M +37.20% | -54.46M +49.07% | -40.65M +48.59% | -35.53M +67.25% | -33.93M +10.20% | -25.00M +54.09% | -30.47M +25.04% | -32.24M +9.28% | -25.17M +25.83% | -19.38M +22.48% | -19.69M +35.36% | -23.52M +27.04% | -45.50M -80.79% | 3.76M +119.42% | -84.95M -- |
Income Tax Expense | -- -- | -1.79M -- | -308.52K -- | -- -- | -- -- | -- -- | 0 +100.00% | 0 -- | 0 -- | 0 -- | 0 -- | 2.17M -- | 0 -- | 0 -- | 0 -- | -62.80K -102.89% | -106.77K -- | 0 -- | -87.76K -- | -- -- | -- -- | -- -- | 0 +100.00% | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income | -6.16M -- | 5.59M -- | -17.95M -- | -8.04M -- | -18.70M -203.53% | -20.76M -471.07% | -26.23M -46.13% | -23.09M -187.04% | -9.48M +49.32% | -34.13M -64.43% | -21.51M +18.02% | -32.35M -40.13% | -6.64M +29.96% | -25.02M +26.71% | -32.96M -53.27% | -29.29M +9.46% | -29.58M -345.53% | -23.54M +5.91% | -38.15M -15.73% | -33.14M -13.13% | -129.17M -336.70% | 19.17M +181.45% | -24.34M +36.20% | -54.40M -64.18% | -82.14M +36.41% | -60.17M -413.85% | -106.95M -339.42% | -79.07M -45.35% | -108.50M -32.09% | -37.78M +37.20% | -54.46M +49.07% | -40.65M +48.59% | -35.53M +67.25% | -33.93M +10.20% | -25.00M +54.09% | -30.47M +25.04% | -32.24M +9.28% | -25.17M +25.83% | -19.38M +22.48% | -19.69M +35.36% | -23.52M +27.04% | -45.50M -80.79% | 3.76M +119.42% | -84.95M -- |
Net Income Attributable to Minority Interests | 85.86K -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | 0 -- | 0 -- | 0 -- | -69.61K -- | -191.85K -- | -445.76K -- | -485.34K -- | -594.35K -753.89% | -469.41K -144.67% | 0 +100.00% | 0 +100.00% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income Attributable to Owners of the Company | -6.25M -- | 5.59M -- | -17.95M -- | -8.04M -- | -18.70M -199.36% | -20.76M -471.07% | -26.23M -46.13% | -23.09M -187.04% | -9.48M +49.32% | -34.13M -64.43% | -21.51M +18.02% | -32.35M -40.13% | -6.64M +29.96% | -25.02M +26.71% | -32.96M -53.27% | -29.22M +9.68% | -29.39M -342.64% | -23.09M +7.70% | -37.66M -14.26% | -32.54M -11.37% | -128.70M -337.96% | 19.17M +183.03% | -24.34M +35.38% | -54.40M -67.18% | -82.14M +36.18% | -60.17M -413.85% | -106.95M -339.42% | -79.07M -45.35% | -108.50M -32.09% | -37.78M +37.20% | -54.46M +49.07% | -40.65M +48.59% | -35.53M +67.25% | -33.93M +10.20% | -25.00M +54.09% | -30.47M +25.04% | -32.24M +9.28% | -25.17M +25.83% | -19.38M +22.48% | -19.69M +35.36% | -23.52M +27.04% | -45.50M -80.79% | 3.76M +119.42% | -84.95M -- |
Net Income Attributable to Common Stockholders | -6.25M -- | 5.59M -- | -17.95M -- | -8.04M -- | -18.70M -199.36% | -20.76M -471.07% | -26.23M -46.13% | -23.09M -187.04% | -9.48M +49.32% | -34.13M -64.43% | -21.51M +18.02% | -32.35M -40.13% | -6.64M +29.96% | -25.02M +26.71% | -32.96M -53.27% | -29.22M +9.68% | -29.39M -342.64% | -23.09M +7.70% | -37.66M -14.26% | -32.54M -11.37% | -128.70M -337.96% | 19.17M +183.03% | -24.34M +35.38% | -54.40M -67.18% | -82.14M +36.18% | -60.17M -413.85% | -106.95M -339.42% | -79.07M -45.35% | -108.50M -32.09% | -37.78M +37.20% | -54.46M +49.07% | -40.65M +48.59% | -35.53M +67.25% | -33.93M +10.20% | -25.00M +54.09% | -30.47M +25.04% | -32.24M +9.28% | -25.17M +25.83% | -19.38M +22.48% | -19.69M +35.36% | -23.52M +27.04% | -45.50M -80.79% | 3.76M +119.42% | -84.95M -- |
Other Comprehensive Income | -132.67K -- | 3.98M -- | -945.84K -- | 200.68K -- | 605.34K +556.27% | -855.01K -121.49% | -1.33M -40.76% | 203.54K +1.42% | 86.86K -85.65% | -1.25K +99.85% | -1.73M -30.25% | -112.77K -155.40% | -137.25K -258.01% | 316.63K +25531.81% | -247.11K +85.75% | 819.18K +826.45% | 441.55K +421.71% | -31.46K -109.94% | -227.79K +7.82% | -1.93M -335.55% | 846.90K +91.80% | 362.20K +1251.40% | -8.32K +96.35% | -9.56K +99.50% | -201 -100.02% | 7.98K -97.80% | -24.30K -192.26% | -175.65K -1737.75% | -191.78K -95310.95% | -235.55K -3052.84% | 186.47K +867.24% | 115.94K +166.01% | -108.47K +43.44% | -59.81K +74.61% | 88.47K -52.55% | -13.61K -111.74% | -13.32K +87.72% | 66.08K +210.47% | -52.21K -159.01% | 14.35K +205.39% | -422 +96.83% | 14.39K -78.23% | 9.39K +117.99% | 37.70K -- |
Total Comprehensive Income | -6.30M -- | 9.57M -- | -18.90M -- | -7.84M -- | -18.10M -187.52% | -21.61M -325.79% | -27.56M -45.86% | -22.88M -191.79% | -9.39M +48.11% | -34.14M -57.93% | -23.24M +15.69% | -32.46M -41.87% | -6.78M +27.85% | -24.70M +27.64% | -33.21M -42.90% | -28.47M +12.30% | -29.14M -329.99% | -23.57M +4.58% | -38.38M -15.56% | -35.06M -23.17% | -128.33M -340.41% | 19.53M +182.88% | -24.35M +36.56% | -54.41M -55.17% | -82.14M +35.99% | -60.16M -407.99% | -106.97M -339.37% | -79.25M -45.65% | -108.69M -32.32% | -38.02M +36.80% | -54.28M +49.26% | -40.53M +48.85% | -35.64M +67.21% | -33.99M +10.60% | -24.92M +54.10% | -30.48M +24.79% | -32.25M +9.52% | -25.10M +26.16% | -19.43M +22.00% | -19.68M +35.44% | -23.52M +27.07% | -45.48M -81.21% | 3.77M +119.42% | -84.91M -- |
Total Comprehensive Income Attributable to Minority Interests | 85.86K -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | 0 -- | 0 -- | 0 -- | -69.61K -- | -191.85K -- | -445.76K -- | -485.34K -- | -594.35K -753.89% | -469.41K -144.67% | 0 +100.00% | 0 +100.00% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Total Comprehensive Income Attributable to Owners of the Company | -6.38M -- | 9.57M -- | -18.90M -- | -7.84M -- | -18.10M -183.65% | -21.61M -325.79% | -27.56M -45.86% | -22.88M -191.79% | -9.39M +48.11% | -34.14M -57.93% | -23.24M +15.69% | -32.46M -41.87% | -6.78M +27.85% | -24.70M +27.64% | -33.21M -42.90% | -28.40M +12.52% | -28.95M -327.16% | -23.12M +6.38% | -37.89M -14.09% | -34.47M -21.37% | -127.86M -341.71% | 19.53M +184.48% | -24.35M +35.74% | -54.41M -57.85% | -82.14M +35.76% | -60.16M -407.99% | -106.97M -339.37% | -79.25M -45.65% | -108.69M -32.32% | -38.02M +36.80% | -54.28M +49.26% | -40.53M +48.85% | -35.64M +67.21% | -33.99M +10.60% | -24.92M +54.10% | -30.48M +24.79% | -32.25M +9.52% | -25.10M +26.16% | -19.43M +22.00% | -19.68M +35.44% | -23.52M +27.07% | -45.48M -81.21% | 3.77M +119.42% | -84.91M -- |
Basic EPS | -0.09 -- | 0.08 -- | -- -- | -0.11 -- | -0.26 -188.89% | -0.28 -450.00% | -0.35 -- | -0.31 -181.82% | -0.13 +50.00% | -0.39 -39.29% | -0.24 +31.43% | -0.36 -16.13% | -0.07 +46.15% | -0.27 +30.77% | -0.34 -41.67% | -0.3 +16.67% | -0.3 -328.57% | -0.23 +14.81% | -0.37 -8.82% | -0.26 +13.33% | -0.83 -176.67% | 0.12 +152.17% | -0.13 +64.86% | -0.27 -3.85% | -0.39 +53.01% | -0.29 -341.67% | -0.49 -276.92% | -0.36 -33.33% | -0.46 -17.95% | -0.15 +48.28% | -0.22 +55.10% | -1.89 -425.00% | -1.61 -250.00% | -1.52 -913.33% | -0.09 +59.09% | -1.31 +30.69% | -1.19 +26.09% | -0.89 +41.45% | -0.54 -500.00% | -0.51 +61.07% | -0.61 +48.74% | -0.87 +2.25% | 0.05 +109.26% | -1.94 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -1.52 -- | -- -- | -1.31 -- | -1.19 -- | -0.89 +41.45% | -- -- | -0.51 +61.07% | -0.61 +48.74% | -0.87 +2.25% | -- -- | -- -- |
Diluted EPS | -0.09 -- | 0.07 -- | -- -- | -0.11 -- | -0.26 -188.89% | -0.28 -500.00% | -- -- | -0.31 -181.82% | -0.13 +50.00% | -0.4 -42.86% | -- -- | -- -- | -0.08 +38.46% | -0.27 +32.50% | -- -- | -0.3 -- | -0.3 -275.00% | -0.25 +7.41% | -- -- | -0.26 +13.33% | -0.83 -176.67% | 0.11 +144.00% | -- -- | -0.27 -3.85% | -0.39 +53.01% | -0.29 -363.64% | -- -- | -0.36 -33.33% | -0.46 -17.95% | -0.15 +48.28% | -- -- | -1.89 -425.00% | -1.61 -250.00% | -1.52 -913.33% | -- -- | -1.31 +30.69% | -1.19 +26.09% | -0.89 +41.45% | -- -- | -0.51 +61.07% | -0.61 +48.74% | -0.87 +2.25% | -- -- | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -1.52 -- | -- -- | -1.31 -- | -1.19 -- | -0.89 +41.45% | -- -- | -0.51 +61.07% | -0.61 +48.74% | -0.87 +2.25% | -- -- | -- -- |
You can ask Aime
Did Inovio Pharmaceuticals beat or miss consensus estimates last quarter?What were the key takeaways from Inovio Pharmaceuticals’s earnings call?What factors drove the changes in Inovio Pharmaceuticals's revenue and profit?What is the market's earnings forecast for Inovio Pharmaceuticals next quarter?What guidance did Inovio Pharmaceuticals's management provide for the next earnings period?What is Inovio Pharmaceuticals's gross profit margin?What is the revenue and EPS growth rate for Inovio Pharmaceuticals year over year?What were the key takeaways from Inovio Pharmaceuticals's earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
